Who owns Kiniksa Pharmaceuticals Ltd?
- Ticker: KNSA
- CUSIP Number: g5269c101
Tip: Access positions for across all investors
Analyze quarterly positions in Kiniksa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Kiniksa Pharmaceuticals stock
Who bought or sold Kiniksa Pharmaceuticals Ltd this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 3.0M | $52M | 0% | Dec 2023 |
|
Fairmount Funds Management | 2.9M | $51M | 17% | Dec 2023 |
|
Baker Bros. Advisors | 2.8M | $49M | 0% | Dec 2023 |
|
Goldman Sachs Group | 909k | $16M | 5% | Dec 2023 |
|
Arrowpoint Asset Management | 715k | $13M | -6% | Dec 2023 |
|
Rice Hall James & Associates | 619k | $12M | -3% | Mar 2024 |
|
Tang Capital Management | 600k | $11M | 0% | Dec 2023 |
|
Caption Management | 491k | $8.6M | 189% | Dec 2023 |
|
Altitude Crest Partners | 456k | $8.0M | 100% | Dec 2023 |
|
Millennium Management | 428k | $7.5M | -29% | Dec 2023 |
|
Dimensional Fund Advisors | 350k | $6.1M | -6% | Dec 2023 |
|
GMT Capital Corp | 342k | $6.0M | -29% | Dec 2023 |
|
Walleye Trading Advisors | 327k | $5.7M | 100% | Dec 2023 |
|
D. E. Shaw & Co | 305k | $5.3M | -4% | Dec 2023 |
|
Connor, Clark & Lunn Investment Management | 259k | $4.5M | 1% | Dec 2023 |
|
Peregrine Capital Management | 236k | $4.7M | 100% | Mar 2024 |
|
Citadel Advisors | 233k | $4.1M | 101% | Dec 2023 |
|
Barclays | 230k | $4.0M | 31% | Dec 2023 |
|
AQR Capital Management | 228k | $4.0M | -30% | Dec 2023 |
|
Healthcare Of Ontario Pension Plan Trust Fund | 228k | $4.0M | -6% | Dec 2023 |
|
Schonfeld Strategic Advisors | 227k | $4.0M | 9% | Dec 2023 |
|
Hudson Bay Capital Management | 215k | $3.8M | -29% | Dec 2023 |
|
Essex Investment Management | 172k | $3.0M | -8% | Dec 2023 |
|
Hussman Econometrics Advisors | 158k | $3.1M | 100% | Mar 2024 |
|
Charles Schwab Investment Management | 157k | $2.7M | -24% | Dec 2023 |
|
Logos Global Management | 150k | $2.6M | 100% | Dec 2023 |
|
Thomas Stevens, CFA" | 140k | $2.8M | -5% | Mar 2024 |
|
Lion Point Capital | 131k | $2.3M | 0% | Dec 2023 |
|
Nordea Investment Management Ab | 127k | $2.5M | 100% | Mar 2024 |
|
Hennion & Walsh Asset Management | 125k | $2.5M | 29% | Mar 2024 |
|
Linden Thomas Advisory Services | 116k | $2.3M | 2% | Mar 2024 |
|
Bank of New York Mellon | 113k | $2.2M | -16% | Mar 2024 |
|
ADAR1 Capital Management | 105k | $1.8M | 100% | Dec 2023 |
|
Tejara Capital | 95k | $1.7M | 172% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 91k | $1.6M | 0% | Dec 2023 |
|
UBS Group | 85k | $1.5M | 36% | Dec 2023 |
|
State of Wisconsin Investment Board | 81k | $1.4M | 227% | Dec 2023 |
|
Arrowstreet Capital, Limited Partnership | 77k | $1.3M | 6% | Dec 2023 |
|
Massachusetts Financial Services | 76k | $1.3M | -3% | Dec 2023 |
|
Hrt Financial | 75k | $1.3M | 100% | Dec 2023 |
|
Trexquant Investment | 72k | $1.3M | -7% | Dec 2023 |
|
Legato Capital Management | 67k | $1.3M | 0% | Mar 2024 |
|
Allspring Global Investments Holdings | 61k | $1.2M | 18% | Mar 2024 |
|
Rhumbline Advisers | 61k | $1.1M | -3% | Dec 2023 |
|
Jane Street | 60k | $1.1M | 490% | Dec 2023 |
|
Principal Financial Group | 59k | $1.2M | 43% | Mar 2024 |
|
Swiss National Bank | 56k | $975k | -8% | Dec 2023 |
|
Jump Financial | 54k | $951k | 100% | Dec 2023 |
|
Bank of America Corporation | 51k | $887k | -55% | Dec 2023 |
|
Citigroup | 46k | $834k | -63% | Dec 2023 |
|
Balyasny Asset Management | 46k | $812k | 100% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 46k | $909k | -40% | Mar 2024 |
|
Jpmorgan Chase & Co | 46k | $806k | 62% | Dec 2023 |
|
Martingale Asset Management | 45k | $796k | 0% | Dec 2023 |
|
ALPS Advisors | 42k | $735k | -41% | Dec 2023 |
|
Alliancebernstein | 40k | $694k | -6% | Dec 2023 |
|
Opaleye Management | 38k | $640k | 100% | Dec 2023 |
|
M^T Bank Corporation | 36k | $639k | -2% | Dec 2023 |
|
Cubist Systematic Strategies | 36k | $630k | 100% | Dec 2023 |
|
New York State Common Retirement Fund | 35k | $612k | 149% | Dec 2023 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 33k | $584k | -5% | Dec 2023 |
|
Credit Suisse | 29k | $507k | 14% | Dec 2023 |
|
Janney Montgomery Scott | 27k | $530k | 8% | Mar 2024 |
|
Franklin Resources | 27k | $469k | 0% | Dec 2023 |
|
Legal & General Group | 25k | $440k | 4% | Dec 2023 |
|
Point72 Middle East FZE | 24k | $425k | 100% | Dec 2023 |
|
Squarepoint Ops | 23k | $399k | -52% | Dec 2023 |
|
Walleye Trading | 21k | $376k | 100% | Dec 2023 |
|
Mirae Asset Global Investments | 21k | $229k | 6% | Mar 2024 |
|
Virtus ETF Advisers | 19k | $336k | 4% | Dec 2023 |
|
Mercer Global Advisors | 19k | $329k | 9% | Dec 2023 |
|
SG Americas Securities | 18k | $311k | 100% | Dec 2023 |
|
MetLife Investment Advisors | 17k | $304k | 0% | Dec 2023 |
|
Victory Capital Management | 17k | $338k | 17% | Mar 2024 |
|
Qrg Capital Management | 16k | $281k | 100% | Dec 2023 |
|
Robeco Institutional Asset Management B V | 16k | $315k | 100% | Mar 2024 |
|
American International | 16k | $274k | 0% | Dec 2023 |
|
Henderson Group | 12k | $217k | 0% | Dec 2023 |
|
Dynamic Technology Lab Private | 12k | $213k | 100% | Dec 2023 |
|
Royal Bank of Canada | 12k | $202k | 64% | Dec 2023 |
|
Ubs Global Asset Management Americas | 11k | $186k | 0% | Dec 2023 |
|
Wells Fargo & Company | 11k | $186k | -69% | Dec 2023 |
|
Aquatic Capital Management | 8.6k | $151k | 100% | Dec 2023 |
|
China Universal Asset Management | 7.7k | $152k | 88% | Mar 2024 |
|
Zurcher Kantonalbank | 7.6k | $149k | 10% | Mar 2024 |
|
Simplex Trading | 5.0k | $99k | 100% | Mar 2024 |
|
Summit Investment Advisors | 3.1k | $54k | 0% | Dec 2023 |
|
State of Wyoming | 2.3k | $41k | 100% | Dec 2023 |
|
Steward Partners Investment Advisory | 2.3k | $40k | 0% | Dec 2023 |
|
Metropolitan Life Insurance Company | 1.8k | $32k | 0% | Dec 2023 |
|
Advisor Group Holdings | 1.0k | $18k | -19% | Dec 2023 |
|
Amalgamated Bank | 1.0k | $20k | -62% | Mar 2024 |
|
Signature | 943.00 | $17k | -3% | Dec 2023 |
|
Adirondack Trust | 875.00 | $17k | 0% | Mar 2024 |
|
GAMMA Investing | 854.00 | $17k | 9% | Mar 2024 |
|
Lindbrook Capital | 660.00 | $13k | 0% | Mar 2024 |
|
Carmichael Hill & Associates | 532.00 | $11k | -32% | Mar 2024 |
|
Parallel Advisors | 518.00 | $9.1k | -24% | Dec 2023 |
|
Fortitude Family Office | 249.00 | $4.9k | 0% | Mar 2024 |
|
CWM | 140.00 | $3.0k | 10% | Mar 2024 |
|
Daiwa Securities Group | 139.00 | $3.0k | 0% | Mar 2024 |
|
NISA Investment Advisors | 58.00 | $1.1k | 93% | Mar 2024 |
|
Covestor | 53.00 | $999.998700 | -54% | Dec 2023 |
|
Nelson, Van Denburg & Campbell Wealth Management | 34.00 | $670.000600 | 100% | Mar 2024 |
|
Riggs Asset Managment | 30.00 | $591.999000 | 100% | Mar 2024 |
|
Pnc Financial Services | 6.00 | $105.000000 | 100% | Dec 2023 |
|
Who sold out of Kiniksa Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Hillhouse Capital Advisors | Sep 2023 | 699k | $12M |
Marshall Wace | Sep 2023 | 158k | $2.7M |
Soleus Capital Management | Sep 2023 | 157k | $2.7M |
AlphaCentric Advisors | Sep 2023 | 110k | $1.9M |
Jackson Creek Investment Advisors | Sep 2023 | 66k | $1.1M |
Parallax Volatility Advisers | Sep 2023 | 60k | $1.0M |
Capula Management | Sep 2023 | 51k | $892k |
Winton Capital | Sep 2023 | 23k | $391k |
Russell Investments | Sep 2023 | 21k | $363k |
Amundi | Sep 2023 | 5.8k | $94k |
IFP Advisors | Sep 2023 | 3.8k | $65k |
Lazard Asset Management | Sep 2023 | 3.5k | $60k |
Newbridge Financial Services Group | Dec 2023 | 300.00 | $5.3k |
Planned Solutions | Dec 2023 | 200.00 | $3.5k |